In adults with MI and LVEF ≥40%, β-blocker therapy reduced a composite adverse outcome at a median 3.5 y

We only have this paper's title and publication details.

Assessment found β-blocker therapy reduces composite adverse outcomes in adults with myocardial infarction, indicating its importance in treatment.